Literature DB >> 19763823

Antidepressant adequacy and work status among medicaid enrollees with disabilities: a restriction-based, propensity score-adjusted analysis.

Eric G Smith1, Alexis D Henry, Jianying Zhang, Fred Hooven, Steven M Banks.   

Abstract

Abstract This cross-sectional study of adult survey respondents with disability and depression (n = 199) enrolled in Massachusetts' Medicaid program examined the association of adequately or inadequately prescribed antidepressant treatment and self-reported work status using conditional logistic regression, controlling for age, gender, race, marital status, education, receipt of SSI/SSDI, self-reported disabling condition, and health status. Confounding by severity was addressed by two methods: restriction of our sample and subsequent stratification by propensity score. Individuals receiving adequate antidepressant treatment had an increased odds of working compared to individuals receiving inadequate treatment, both in analyses in which restriction was used to limit confounding (OR = 3.45, 95% CI = 1.15-10.32, P < .03), and in analyses which combined restriction with adjustment by propensity score stratification (OR = 3.04, 95% CI = 1.01-9.62, P < .05). Among this sample of Medicaid enrollees with disability and depression, those receiving adequate antidepressant treatment were significantly more likely to report working.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763823     DOI: 10.1007/s10597-009-9199-2

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  27 in total

1.  Propensity score methods in drug safety studies: practice, strengths and limitations.

Authors:  J Wang; P T Donnan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2001 Jun-Jul       Impact factor: 2.890

2.  Rare outcomes, common treatments: analytic strategies using propensity scores.

Authors:  Leonard E Braitman; Paul R Rosenbaum
Journal:  Ann Intern Med       Date:  2002-10-15       Impact factor: 25.391

3.  Labor force activity among Australians with musculoskeletal disorders comorbid with depression and anxiety disorders.

Authors:  Geoff Waghorn; David Chant; Chris Lloyd
Journal:  J Occup Rehabil       Date:  2006-06

4.  Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results.

Authors:  Sebastian Schneeweiss; Amanda R Patrick; Til Stürmer; M Alan Brookhart; Jerry Avorn; Malcolm Maclure; Kenneth J Rothman; Robert J Glynn
Journal:  Med Care       Date:  2007-10       Impact factor: 2.983

5.  The effects of primary care depression treatment on patients' clinical status and employment.

Authors:  Michael Schoenbaum; Jürgen Unützer; Daniel McCaffrey; Naihua Duan; Cathy Sherbourne; Kenneth B Wells
Journal:  Health Serv Res       Date:  2002-10       Impact factor: 3.402

6.  Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective.

Authors:  Murray B Stein; Brian J Cox; Tracie O Afifi; Shay-Lee Belik; Jitender Sareen
Journal:  Psychol Med       Date:  2006-05       Impact factor: 7.723

7.  Clinical issues related to depression in schizophrenia: an international survey of psychiatrists.

Authors:  D D Addington; J M Azorin; I R H Falloon; J Gerlach; S R Hirsch; S G Siris
Journal:  Acta Psychiatr Scand       Date:  2002-03       Impact factor: 6.392

8.  Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.

Authors:  Lori Altshuler; Trisha Suppes; David Black; Willem A Nolen; Paul E Keck; Mark A Frye; Susan McElroy; Ralph Kupka; Heinz Grunze; Jörg Walden; Gabrielle Leverich; Kirk Denicoff; David Luckenbaugh; Robert Post
Journal:  Am J Psychiatry       Date:  2003-07       Impact factor: 18.112

9.  Cost of lost productive work time among US workers with depression.

Authors:  Walter F Stewart; Judith A Ricci; Elsbeth Chee; Steven R Hahn; David Morganstein
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

10.  Treatments of depression and the functional capacity to work.

Authors:  J Mintz; L I Mintz; M J Arruda; S S Hwang
Journal:  Arch Gen Psychiatry       Date:  1992-10
View more
  5 in total

1.  Adherence and healthcare utilization among older adults with COPD and depression.

Authors:  Jennifer S Albrecht; Bilal Khokhar; Ting-Ying Huang; Yu-Jung Wei; Ilene Harris; Patience Moyo; Peter Hur; Susan W Lehmann; Giora Netzer; Linda Simoni-Wastila
Journal:  Respir Med       Date:  2017-06-03       Impact factor: 3.415

2.  Gains in employment status following antidepressant medication or cognitive therapy for depression.

Authors:  Jay C Fournier; Robert J DeRubeis; Jay Amsterdam; Richard C Shelton; Steven D Hollon
Journal:  Br J Psychiatry       Date:  2014-06-12       Impact factor: 9.319

3.  New episodes of depression among Medicare beneficiaries with chronic obstructive pulmonary disease.

Authors:  Jennifer S Albrecht; Ting-Ying Huang; Yujin Park; Patricia Langenberg; Ilene Harris; Giora Netzer; Susan W Lehmann; Bilal Khokhar; Linda Simoni-Wastila
Journal:  Int J Geriatr Psychiatry       Date:  2015-08-18       Impact factor: 3.485

4.  Adherence to Maintenance Medications among Older Adults with Chronic Obstructive Pulmonary Disease. The Role of Depression.

Authors:  Jennifer S Albrecht; Yujin Park; Peter Hur; Ting-Ying Huang; Ilene Harris; Giora Netzer; Susan W Lehmann; Patricia Langenberg; Bilal Khokhar; Yu-Jung Wei; Patience Moyo; Linda Simoni-Wastila
Journal:  Ann Am Thorac Soc       Date:  2016-09

5.  An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis.

Authors:  Atsushi Kuga; Toshinaga Tsuji; Shinji Hayashi; Mako Matsubara; Shinji Fujikoshi; Hirofumi Tokuoka; Aki Yoshikawa; Rodrigo Escobar; Kazuhide Tanaka; Takaharu Azekawa
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-04       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.